Plus   Neg

Mediclinic FY21 Revenue Down Around 3.0% - Quick Facts

Mediclinic International plc (MDC.L) reported that its fiscal 2021 Group revenue was down around 3.0%, reflecting significant impact of initial COVID-19-related lockdowns and restrictions. For the second half, year-on-year revenue growth was approximately 1.0%.

For fiscal 2021, the Group delivered an EBITDA margin of around 14.0% compared to 17.5%, previous year. The Group noted that the stronger demand in the second half of the year supported an improved margin trend. Total capital expenditure for the period is expected to be around 150 million pounds compared to 192 million pounds, previous year.

The Group expects to deliver growth in revenue and EBITDA across all three divisions during fiscal 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT